Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement

American Journal of Kidney Diseases

Volumn 33, Issue 4, 1999, Pages 709-717

  Johannsson, G ^a   Bengtsson, B A ^a   Ahlmen, J ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Albumin; Catabolism; Dialysis; Growth hormone; Muscle strength

Indexed keywords

ALBUMIN; HUMAN GROWTH HORMONE; POTASSIUM; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAND GRIP; HEMODIALYSIS; HUMAN; IMPEDANCE; MALE; METABOLIC DISORDER; MUSCLE STRENGTH; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; TOTAL BODY POTASSIUM;

EID: 0032903480     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70223-4     Document Type: Article

References (41)

1. S Schön Swedish Registry for Active Treatment of Uremia 1996 Department of Nephrology, Skaraborgs Hospital
2. CR Blagg Importance of nutrition in dialysis patients Am J Kidney Dis 17 1991 458 461
3. P Marckman Nutritional status of patients on hemodialysis and peritoneal dialysis Clin Nephrol 29 1988 75 78
4. W Mitch R May B Marconi W Bruml Protein and amino acid metabolism in uremia: Influence of metabolic acidosis Kidney Int 27 1989 205 207
5. M Akmal SG Massry DA Goldstein P Fanti A Weisz RA DeFronzo Role of parathyroid hormone in the glucose intolerance of chronic renal failure J Clin Invest 75 1985 1037 1044
6. J Bergström Protein catabolic factors in patients on renal replacement therapy Adv Exp Med Biol 260 1989 1 9
7. C Compher JL Mullen CF Barker Nutritional support in renal failure Surg Clin North Am 71 1991 597 608
8. C Foulkes D Goldstein M Kelly J Hunt Indications for the use of intradialytic parenteral nutrition in the malnourished hemodialysis patient Ren Nutr 1 1991 23 33
9. JD Veldhuis A Iranmanesh MJ Wilkowski E Samojlik Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men Eur J Endocrinol 131 1994 489 498
10. B Tönshoff JD Veldhuis U Heinrich O Mehls Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease Pediatr Res 37 1995 86 93
11. RV Garcia-Mayor AJ Perez A Gandara A Andrade F Mallo FF Casanueva Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects Clin Endocrinol (Oxf) 39 1993 337 343
12. LS Phillips AC Fusco TG Unterman F del Greco Somatomedin inhibitor in uremia J Clin Endocrinol Metab 59 1984 764 774
13. D Powell R Rosenfeld J Sperry B Baker R Hintz Serum concentrations of insulin-like growth factor (IGF)-I, IGF-II and unsaturated somatomedin carrier proteins in children with chronic renal failure Am J Kidney Dis 10 1987 287 292
14. RH Mah YK Pak End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure Kidney Int 50 1996 400 406
15. B Tönshoff O Mehis U Heinrich WF Blum MB Ranke A Schauer Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease J Pediatr 116 1990 561 566
16. AC Hokken Koelega T Stijnen SM de Muinck Keizer Schrama JM Wit ED Wolff MC de Jong RA Donckerwolcke NC Abbad A Bot WF Blum Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure Lancet 338 1991 585 590
17. TA Ikizler RL Wingard JA Breyer G Schulman RA Parker RM Hakim Short-term effects of recombinant human growth hormone in CAPD patients Kidney Int 46 1994 1178 1183
18. TR Ziegler JM Lazarus LS Young R Hakim DW Wilmore Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis J Am Soc Nephrol 2 1991 1130 1135
19. 40K Int J Obes 12 1988 249 266
20. G Stelin J Ahlmén B Morelli V Tylén Computed tomography and total-body potassium measurements of patients on continous ambulatory peritoneal dialysis ASAIO J 8 1985 46 49
21. PS Kurtin AC Shapiro H Tomita D Raizman Volume status and body composition of chronic dialysis patients: Utility of bioelectrical impedance plethysmography Am J Nephrol 10 1990 363 367
22. J Daugirdas Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error J Am Soc Nephrol 4 1993 1205 1213
23. UM Nordenskjöld G Grimby Grip force in patients with rheumatoid arthritis and fibromyalgia and in healthy subjects. A study with Grippit instrument Scand J Rheumatol 22 1993 14 19
24. JNS Matthews DG Altman MJ Campbell P Royston Analysis of serial measurements in medical research BMJ 300 1990 230 235
25. EG Lowrie NL Lew Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities Am J Kidney Dis 15 1990 458 482
26. MV Kaminski Jr EG Lowrie SG Rosenblatt T Haase Malnutrition is lethal, diagnosable and treatable in ESRD patients Transplant Proc 23 1991 1810 1815
27. B Techan C Schleifer J Brown Urea kinetic modeling is an appropriate assessment of adequacy Semin Dial 5 1992 189 192
28. WF Owen Jr NL Lew SM Yan Liu EG Lowrie JM Lazarus The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis N Engl J Med 329 1993 1001 1006
29. LM Kernoff BL Pimstone J Solomon JF Brock The effect of hypophysectomy and growth hormone replacement on albumin synthesis and catabolism in the rat Biochem J 124 1971 529 535
30. JJ Zachwieja DM Bier KE Yarasheski Growth hormone administration in older adults: Effects on albumin synthesis Am J Physiol 266 1994 E840 E844
31. O Mehls E Titz E-B Hunziker P Eggli U Heinrich J Zapf Improvement of growth and food utilization by human recombinant growth hormone in uremia Kidney Int 33 1988 45 52
32. DA Fryburg RA Gelfand EJ Barrett Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans Am J Physiol 260 1991 E499 E504
33. DL Russel-Jones AJ Weissberger SB Bowes JM Kelly M Thomas AM Umpley RH Jones PH Sönksen The effects of growth hormone on protein metabolism in adult growth hormone deficient patients Clin Endocrinol (Oxf) 38 1993 427 431
34. G Garibotto A Barreca R Russo A Sofia P Araghi A Cesarone M Malaspina F Fiorini F Minuto A Tizianello Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients J Clin Invest 99 1997 97 105
35. AM Klidjian KJ Foster RM Kammerling A Cooper SJ Karran Relation of anthropodometric and dynamometricvariables to serious postoperative complications BMJ 281 1980 899 901
36. JA Windsor GL Hill Grip strength: A measure of the proportion of protein loss in surgical patients Br J Surg 75 1988 880 882
37. IH Fahal GM Bell JM Bone RH Edwards Physiological abnormalities of skeletal muscle in dialysis patients Nephrol Dial Transplant 12 1997 119 127
38. G Schulman R Wingard RL Hutchinson P Lawrence RM Hakim The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients Am J Kidney Dis 21 1993 527 534
39. G Johannsson T RosÉn B-Å Bengtsson Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults Clin Endocrinol (Oxf) 47 1997 571 581
40. CJ Bagatell WJ Bremner Androgens in men–Uses and abuses N Engl J Med 334 1996 707 714
41. G Johannsson P Mårin L Lönn M Ottosson K Stenlöf P Björntorp L Sjöström B-Å Bengtsson Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure J Clin Endocrinol Metab 82 1997 727 734